Gain Therapeutics, Inc. (NASDAQ:GANX) Cap table

Gain Therapeutics, Inc.

Cap table

Built by 6ix from Gain Therapeutics, Inc.’s releases · as of Oct 30, 2026

Common shares
44,525,347
Fully diluted
44,525,347

Fully diluted

LineSharesAs of
Common shares44,525,347Oct 30, 2026

Share count over time

CountShares
Oct 30, 202644,525,347
Sep 30, 202644,324,134